Endo Announces Anticipated Further Stay of Compounding Litigation Due to Lapse of Government Appropriations

DUBLIN, Dec. 31, 2018 /PRNewswire/ -- Endo International plc ("Endo"; NASDAQ: ENDP) today announced that, due to the ongoing federal government shutdown, the U.S. Food and Drug Administration (the "FDA") has requested a further stay of Endo's ongoing litigation against the FDA for the...

from PR Newswire: https://prn.to/2AmpD78